ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,304.72
      0.70%
      US Tech 100
      18,318.00
      0.95%
      Dow Jones
      39,069.59
      0.01%
      Brent Oil
      81.965
      0.00%
      Bitcoin
      69,029.06
      -0.35%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Axonyx (AXYX)

      7. Axonyx (AXYX) News

      AXYX

      Axonyx (AXYX)

      Axonyx
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AXYX
      DateTimeSourceHeadlineSymbolCompany
      09/28/20064:15PMBusiness WireAxonyx Stockholders Approve Merger with TorreyPines Therapeutics Inc.NASDAQ:AXYXAxonyx
      09/21/200611:00AMPR Newswire (US)TorreyPines Therapeutics to Present at the UBS Global Life Sciences ConferenceNASDAQ:AXYXAxonyx
      08/30/200611:00AMPR Newswire (US)TorreyPines Therapeutics to Present at the Thomas Weisel Partners 2006 Healthcare ConferenceNASDAQ:AXYXAxonyx
      08/08/20068:30AMBusiness WireAXONYX Inc. Announces Second Quarter 2006 Financial ResultsNASDAQ:AXYXAxonyx
      08/07/20069:30AMPR Newswire (US)TorreyPines Therapeutics Initiates Phase I Clinical Trial of NGX426, a Novel Oral Therapy for Migraine and Neuropathic PainNASDAQ:AXYXAxonyx
      08/04/20064:30PMBusiness WireAxonyx Receives Notice Related to Nasdaq Minimum Bid Price RuleNASDAQ:AXYXAxonyx
      07/24/20069:30AMPR Newswire (US)TorreyPines Therapeutics Completes Second Phase I Study for NGX267, a Selective M1 Agonist for the Treatment of Alzheimer's DisNASDAQ:AXYXAxonyx
      06/20/200611:00AMPR Newswire (US)TorreyPines Therapeutics to Present at the Jefferies & Company Life Sciences ConferenceNASDAQ:AXYXAxonyx
      06/09/200611:34AMPR Newswire (US)TorreyPines Therapeutics to Present at the 2006 Pacific Growth Equities Life Sciences Growth ConferenceNASDAQ:AXYXAxonyx
      06/08/20068:00AMBusiness WireAxonyx and TorreyPines to Host Webcast and Conference Call on Announced MergerNASDAQ:AXYXAxonyx
      06/08/20066:30AMBusiness WireAxonyx and TorreyPines Therapeutics Announce Merger Agreement; Transaction Creates Robust Portfolio in the CNS Disease AreaNASDAQ:AXYXAxonyx
      05/15/20064:15PMBusiness WireAxonyx Announces Completion of the Multiple-Dose Phase I Study of Posiphen(TM)NASDAQ:AXYXAxonyx
      05/10/20065:30PMBusiness WireAxonyx Inc. Reports First Quarter 2006 Financial ResultsNASDAQ:AXYXAxonyx
      05/09/20069:28AMBusiness WireAxonyx to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference; Presentation to be Web Cast Live on CorporatNASDAQ:AXYXAxonyx
      04/24/20068:30AMBusiness WireResearcher Reports Data on Effects of Posiphen(TM) on Human Neuronal Stem Cells; Posiphen May Support Stem Cell TransplantationNASDAQ:AXYXAxonyx
      04/20/20064:30PMBusiness WireAxonyx Reports Data on Effects of Phenserine on the Brains of Alzheimer's Disease Patients; PET Scans Show Increased Brain NeurNASDAQ:AXYXAxonyx
      04/19/20064:30PMBusiness WireAxonyx Reports Data on Stabilized Brain Volumes in Alzheimer's Disease Patients Treated with Phenserine; Analysis of Brain ScanNASDAQ:AXYXAxonyx
      03/16/20064:15PMBusiness WireAxonyx Reports Fourth Quarter and Full Year 2005 Financial ResultsNASDAQ:AXYXAxonyx
      03/08/20064:24PMBusiness WireAxonyx Regains Compliance with Nasdaq Minimum Bid Price RuleNASDAQ:AXYXAxonyx
      02/23/20068:33AMBusiness WireAxonyx to Present at the Wall Street Analyst Forum; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
      02/14/20068:33AMBusiness WireAxonyx Reports Phenserine Associated with Significant Amyloid Reduction in Phase I Trial; Results Support Dual Mechanisms of ActNASDAQ:AXYXAxonyx
      02/07/20069:00AMBusiness WireAxonyx to Present at BIO CEO & Investor Conference 2006; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
      01/31/20068:30AMBusiness WireAxonyx Announces Acceptance of Four Abstracts Highlighting Phenserine and Posiphen by the 9th International Geneva/Springfield SNASDAQ:AXYXAxonyx
      01/24/20068:30AMBusiness WireAxonyx Completes First Phase I Trial with Posiphen for Alzheimer's Disease ProgressionNASDAQ:AXYXAxonyx
      01/04/20068:30AMBusiness WireAxonyx Announces License of Phenserine to Daewoong Pharmaceutical Company for South KoreaNASDAQ:AXYXAxonyx
      11/09/20058:30AMBusiness WireAxonyx Inc. Announces Third Quarter Financial ResultsNASDAQ:AXYXAxonyx
      11/07/20054:47PMBusiness WireAxonyx Provides Update on Clinical Development Program and Strategic InitiativesNASDAQ:AXYXAxonyx
      10/26/20058:00AMBusiness WireAxonyx to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference; Presentation to Be Web Cast Live on Corporate WNASDAQ:AXYXAxonyx
      09/20/20059:00AMBusiness WireAxonyx Announces Results of Curtailed Phase III Clinical Trials for Phenserine in Alzheimer's DiseaseNASDAQ:AXYXAxonyx
      09/15/20058:30AMBusiness WireAxonyx to Present at the UBS 2005 Global Life Sciences Conference; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
       Showing the most relevant articles for your search:NASDAQ:AXYX